Response to Smyth & McCarron: Increases in cannabis-attributable emergency department visits during different phases of the pre- and post-legalization period are multi-factorial

Daniel T Myran^{1

2

3}, Michael Pugliese³, Peter Tanuseputro^{1

3

4

5}, Monica Taljaard^{1

6}

Affiliations

¹ Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.
³ Institute for Clinical Evaluative Sciences (ICES), Ottawa, Ontario, Canada.
⁴ Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁵ Bruyère Research Institute, Ottawa, Ontario, Canada.
⁶ School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

PMID: 36738192
DOI: 10.1111/add.16152

Comment

Response to Smyth & McCarron: Increases in cannabis-attributable emergency department visits during different phases of the pre- and post-legalization period are multi-factorial

Daniel T Myran et al. Addiction. 2023 May.

. 2023 May;118(5):980-982.

doi: 10.1111/add.16152. Epub 2023 Feb 27.

Authors

Daniel T Myran^{1

2

3}, Michael Pugliese³, Peter Tanuseputro^{1

3

4

5}, Monica Taljaard^{1

6}

Affiliations

¹ Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
² Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada.
³ Institute for Clinical Evaluative Sciences (ICES), Ottawa, Ontario, Canada.
⁴ Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁵ Bruyère Research Institute, Ottawa, Ontario, Canada.
⁶ School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.

PMID: 36738192
DOI: 10.1111/add.16152

No abstract available

Keywords: Cannabis; ED visits due to cannabis; cannabis harms; epidemiology; interrupted time-series; legalization; recreational cannabis commercialization; recreational cannabis legalization.

PubMed Disclaimer

Comment on

The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
Myran DT, Pugliese M, Tanuseputro P, Cantor N, Rhodes E, Taljaard M. Myran DT, et al. Addiction. 2022 Jul;117(7):1952-1960. doi: 10.1111/add.15834. Epub 2022 Feb 17. Addiction. 2022. PMID: 35170149
Increase in cannabis-related emergency department presentations in the period immediately before legalization requires explanation.
Smyth BP, McCarron P. Smyth BP, et al. Addiction. 2023 May;118(5):979-980. doi: 10.1111/add.16128. Epub 2023 Jan 20. Addiction. 2023. PMID: 36606761 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

452360/CIHR/Canada

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Smyth & McCarron: Increases in cannabis-attributable emergency department visits during different phases of the pre- and post-legalization period are multi-factorial

Affiliations

Response to Smyth & McCarron: Increases in cannabis-attributable emergency department visits during different phases of the pre- and post-legalization period are multi-factorial

Authors

Affiliations

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources